In a recent study posted to the medRxiv* preprint server, researchers investigated whether the second booster dose of monovalent coronavirus disease 2019 (COVID-19) messenger ribonucleic acid (mRNA) ...
Credit: Getty Images. This randomized, placebo-controlled, double-blind phase 3 trial aimed to evaluate the safety, efficacy, and immunogenicity of a combined protein-based vaccination strategy. This ...
In a recent Morbidity and Mortality Weekly Report, the United States Centers for Disease Prevention and Control (US-CDC) reported findings of the surveillance of nursing home residents by the National ...
During the omicron period, an increased risk for ICU admission and increased time to discharge were still seen in association with hospital-onset SARS-CoV-2. HealthDay News — During the omicron era, ...
Puritize®, the first scientifically proven, patented product available for home use for killing more than 99.9% of germs, bacteria and viruses, including SARS-CoV-2, on personal items, is now ...
MILWAUKEE--(BUSINESS WIRE)--Dr. Richard Matner, President of PlantPharm BioMed, Ltd. will be presenting at the International Symposium on One Health Research: Improving Food Security and Resilience, ...
"I want to go home, because this is my first year studying abroad. . . . But I care about my health, too." Severe acute respiratory syndrome, or SARS, is creating concerns on college campuses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback